EMG
MGNX icon

Ellington Management Group’s MacroGenics MGNX Stock Holding History

Ellington Management Group’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,100
Closed -$205K – 727
2017
Q3 		$205K Buy
+11,100
New +$192K 0.04% 522

Other funds holding MGNX

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ellington Management Group's MGNX Position: Q4 2017 in Review

Ellington Management Group sold out of MacroGenics (MGNX) in Q4 2017, closing a stake of 11,100 shares — an estimated $205K sold.

Ellington Management Group first reported a position in MGNX in Q3 2017 and held it in 1 quarter. The position peaked at $205K in Q3 2017. 119 funds tracked by Wall St. Rank hold MGNX as of Q4 2017.

  • Ellington Management Group reported no remaining MacroGenics position as of Q4 2017 after selling out during the quarter.
  • Ellington Management Group sold 11,100 MacroGenics shares in Q4 2017, an estimated $205K.
  • Ellington Management Group first reported a position in MacroGenics in Q3 2017 and held it in 1 quarter.
  • Ellington Management Group's MacroGenics position peaked at $205K in Q3 2017.
  • 119 funds tracked by Wall St. Rank held MacroGenics as of Q4 2017.

Based on Ellington Management Group's 13F filing for Q4 2017, filed 14 Feb 2018.